ArticleGalen medical journal2026
Reasons for Retraction of Biomedical Articles Written by Eastern Mediterranean and Turkish Authors; A Comprehensive Cross-Sectional Study During 2010-2019 : Short title: Reasons for Retraction of Biomedical Articles.
Article in Galen medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Article retraction means removing a published article from the journal because of ethical issues or scientific errors in order to correct the literature. In this study, we aimed to determine the reasons for retracting biomedical articles written by authors from Iran, Saudi Arabia, Pakistan, Egypt, and Turkey. Materials and Methods: This cross-sectional study included all retracted biomedical articles with first authors affiliated with Iran, Saudi Arabia, Pakistan, Egypt, or Turkey, retracted between September 1, 2010, and September 1, 2019. Data were extracted from Retraction Watch, MEDLINE, PubMed Central (PMC), Clarivate Analytics, and Scopus. Each article's information was entered into a data collection form and analyzed using SPSS version 24. Results: Of 436 retracted articles, Iran had the highest number (223), followed by Turkey (80), Egypt (72), Saudi Arabia (35), and Pakistan (26). Common causes of retraction included plagiarism, duplication, authorship issues, and fake peer review. In Iran, fake peer review (42.6%) and authorship issues (41.3%) were most prevalent. Significant inter- country differences were found in retraction frequency and causes. The most affected fields were biology, biochemistry, oncology, cardiovascular, surgery, and pathology. Conclusion: The results showed that scientific misconducts (plagiarism, duplication, authorship issues, and fake peer review) were the main reasons for retracting the articles in the five studied countries. To reduce such misconducts, regional regulatory policies, improved editorial practices, and enhanced research ethics training are urgently needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.